
Chlorthalidone (12.5mg) + Telmisartan (80mg)
Active composition
+1 more active ingredient
Telmisartan selectively blocks angiotensin II receptors, leading to vasodilation and decreased blood pressure.
Medical applications
Eritel CH 80 Tablet contains a combination of Telmisartan 80 mg and Chlorthalidone 12.5 mg, formulated for the management of hypertension. Telmisartan is an angiotensin II receptor blocker (ARB) that selectively inhibits the binding of angiotensin II to the AT1 receptor, thereby reducing vasoconstriction and aldosterone secretion, resulting in lowered blood pressure. Chlorthalidone is a thiazide-like diuretic that promotes the excretion of sodium and water by inhibiting sodium reabsorption in the distal convoluted tubules of the kidneys, contributing to a reduction in blood volume and peripheral resistance. The synergistic effect of these agents provides effective and sustained blood pressure control, reducing the risk of cardiovascular events such as stroke, myocardial infarction, and heart failure. Eritel CH 80 is indicated for patients who require combination therapy for hypertension, especially when monotherapy is insufficient. It should be used with caution in patients with renal or hepatic impairment, electrolyte imbalances, or hypersensitivity to sulfonamides. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during treatment. This medication should be taken as prescribed by a healthcare professional, and patients should be advised to maintain lifestyle modifications alongside pharmacotherapy for optimal outcomes.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Eritel CH 80 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Eritel CH 80 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Medical Advice
Eritel CH 80 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Eritel CH 80 Tablet may be needed. Please consult your doctor. Use of Eritel CH 80 Tablet is not recommended in these patients.
Exercise Caution
Eritel CH 80 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Eritel CH 80 Tablet should be used with caution in patients with liver disease. Dose adjustment of Eritel CH 80 Tablet may be needed. Please consult your doctor. Use of Eritel CH 80 Tablet is not recommended in patients with severe liver disease.
Regular Checkup
0 reviews for Eritel CH 80 Tablet

Telmisartan (80mg) + Chlorthalidone (12.5mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Telmisartan selectively blocks angiotensin II receptors, leading to vasodilation and decreased blood pressure.
Medical applications
Eritel CH 80 Tablet contains a combination of Telmisartan 80 mg and Chlorthalidone 12.5 mg, formulated for the management of hypertension. Telmisartan is an angiotensin II receptor blocker (ARB) that selectively inhibits the binding of angiotensin II to the AT1 receptor, thereby reducing vasoconstriction and aldosterone secretion, resulting in lowered blood pressure. Chlorthalidone is a thiazide-like diuretic that promotes the excretion of sodium and water by inhibiting sodium reabsorption in the distal convoluted tubules of the kidneys, contributing to a reduction in blood volume and peripheral resistance. The synergistic effect of these agents provides effective and sustained blood pressure control, reducing the risk of cardiovascular events such as stroke, myocardial infarction, and heart failure. Eritel CH 80 is indicated for patients who require combination therapy for hypertension, especially when monotherapy is insufficient. It should be used with caution in patients with renal or hepatic impairment, electrolyte imbalances, or hypersensitivity to sulfonamides. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during treatment. This medication should be taken as prescribed by a healthcare professional, and patients should be advised to maintain lifestyle modifications alongside pharmacotherapy for optimal outcomes.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Eritel CH 80 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Eritel CH 80 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Medical Advice
Eritel CH 80 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Eritel CH 80 Tablet may be needed. Please consult your doctor. Use of Eritel CH 80 Tablet is not recommended in these patients.
Exercise Caution
Eritel CH 80 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Eritel CH 80 Tablet should be used with caution in patients with liver disease. Dose adjustment of Eritel CH 80 Tablet may be needed. Please consult your doctor. Use of Eritel CH 80 Tablet is not recommended in patients with severe liver disease.
Regular Checkup
0 reviews for Eritel CH 80 Tablet















